Search for: [Abstract = "with controls without VTE. A 3\-day administration of atorvastatin \(40 mg\/d\) alters favorably fibrin clot properties, however more explicitly in VTE patients than in controls, in whom only lysis is accelerated. Atorvastatin\-induced improvement in fibrin clot permeability and susceptibility to lysis is independent to any changes in lipid profile. The presence of RVT modulates fibrin clot properties and its alteration following statin use. The current study demonstrates that even a 3\-day course of atorvastatin alters favorably fibrin clot structure\/function, which might reflect additional antithrombotic properties of statins in VTE patients."]

Number of results: 1